Asset Inc accumulated 69,983 shares. Profit Inv Mngmt Lc invested in 6,609 …
Mr. Anthony C. Hooper is the Executive Vice President - Global Commercial Operations of Amgen Inc. From March 2010 to October 2011, Mr. Hooper was Senior Vice President, Commercial Operations and President, U.S., Japan and …
Amica Mutual Insurance Co. cut its stake in shares of Amgen (NASDAQ:AMGN) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,770 shares of the medical research companys stock …
AMGN closed Mar 28, 2018's trading session at $170.46. In the past year, the stock has hit a 52-week low of $152.16 and 52-week high of $201.23. Amgen stock has been showing support around $165.85 and resistance in the $174.81 range. …
The biotech sector was in focus last week with Protagonist's stock plunging on news of discontinuation of a phase IIb study and Verona Pharma stock surging on positive top-line data from COPD study among others.
Mr. Brian M. McNamee is the Executive Vice President - Full Potential Initiatives of Amgen Inc. Mr. McNamee joined the Company in June 2001 as Senior Vice President, Human Resources. From November 1999 to June 2001, Mr. …
AMGN stock, however, continues to look promising, and this latest pullback in fact looks to provide a better reward-to-risk opportunity to buy again. The last time I mused about Amgen on Sept. 27, I offered that despite the stock’s …
For a hedged play on Amgen (AMGN) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a May 18, 2018 $175 covered call for a net debit in the $170.16 area. That is also the break-even stock price for the covered …
Even though Amgen, Inc. (NASDAQ:AMGN) stock has one of the best-performing charts I’ve seen, it doesn’t get the respect it deserves. From a valuation perspective, it sells at a sizable discount to its competitors. Its price-earnings …